Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease.

Yazdani SK, Lei B, Cawthon CV, Cooper K, Huett C, Giangrande PH, Miller FJ Jr

Open source

DOI
10.1016/j.omtn.2022.08.007
Published
2022 Sep 13
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2022.08.007,
  title = {Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease.},
  author = {Yazdani SK and Lei B and Cawthon CV and Cooper K and Huett C and Giangrande PH and Miller FJ Jr},
  year = {2022},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2022.08.007},
  url = {https://doi.org/10.1016/j.omtn.2022.08.007}
}

RIS

TY  - JOUR
TI  - Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease.
AU  - Yazdani SK
AU  - Lei B
AU  - Cawthon CV
AU  - Cooper K
AU  - Huett C
AU  - Giangrande PH
AU  - Miller FJ Jr
PY  - 2022
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2022.08.007
UR  - https://doi.org/10.1016/j.omtn.2022.08.007
ER  -

APA

SK, Y., B, L., CV, C., K, C., C, H., PH, G., & Jr, M. F. (2022). Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2022.08.007

Source records